Drilldown: Medicines
Appearance
Medicines > fda max
:
4.5 mg/day (Parkinson disease); 0.5 mg/day (restless legs syndrome)
or
No fixed maximum; titrated to TSH target
& onset:
Postprandial glucose effect within days; HbA1c by 12 weeks 
:
4.5 mg/day (Parkinson disease); 0.5 mg/day (restless legs syndrome)
or
No fixed maximum; titrated to TSH target
& onset:
Postprandial glucose effect within days; HbA1c by 12 weeks 
Use the filters below to narrow your results.
There are no results for this report.

